Imunon, Inc. — Director's Dealing 2022

Mar 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2022-03-04

Reporting Person: Lindborg Stacy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-04	Option to Purchase Celsion Corporation Common Stock	$4.60	A	2500	Acquired	2032-03-04	Celsion Corporation Common Stock (2500)	Direct

Footnotes

F1: Represents the per share per share fair value of the common stock based on the closing price of a share of Celsion Stock on the date of the award.

F2: The options vest as follows: 1/3 on the date of grant; 1/3 on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant.